Actively Recruiting

All Genders
Healthy Volunteers
ID07048106

Natural History and Structural Consequences of a Diseased Bruch's Membrane in Pseudoxanthoma Elasticum (PXE)

Led by University Hospital, Bonn · Updated on 2025-07-02

100

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are conducting a monocentric observational study at the University Eye Hospital Bonn to explore the natural history and structural effects of a diseased Bruch's membrane (BrM) in people with Pseudoxanthoma Elasticum (PXE). The study aims to analyze BrM changes, choriocapillaris blood flow deficits, progression of retinal atrophy, and how different ABCC6 gene mutations relate to disease features and severity. The goal is to provide insights that could guide personalized treatments and improve patient counseling. The study will include 100 genetically confirmed PXE patients and 100 healthy controls. Participants will undergo non-invasive imaging methods such as high-resolution optical coherence tomography (OCT), OCT angiography, fundus photography, and infrared reflectance imaging. Blood samples will also be collected. Data will be gathered over a 10-year period, with specific attention to changes observed over two years, including the size of 'Peau d'orange', BrM alterations, choriocapillaris flow voids, and angioid streak length. Participants will be asked to hold still during imaging sessions to ensure accurate data capture. The study involves regular monitoring of eye structures and blood flow, as well as genetic analysis. Researchers will measure disease progression through various imaging outcomes and gene mutation correlations. Although no direct benefit is expected for participants, the findings may help shape future clinical trials and improve care for PXE patients.

CONDITIONS

Brief Title

Progression Assessment of PXE-associated Alterations

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • PXE diagnosis based on Plomp et al. criteria
  • Clear ocular media
  • Ability to hold head still for image acquisition
Not Eligible

You will not qualify if you...

  • Any eye disease not related to PXE
  • Systemic diseases that prevent study examinations

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 2 years

Participants undergo imaging and examination to assess the structure of Bruch's Membrane and related ocular features.

Periodic imaging visits over 2 years

Long-term Monitoring

Duration - 2 years

Participants are monitored over time to evaluate progression of PXE-associated alterations in ocular structures.

Follow-up visits for imaging and assessments over 2 years

Trial Site Locations

Total: 1 location

1

Department of Ophthalmology, University Hospital Bonn, Germany

Bonn, North Rhine-Westphalia, Germany, 53125

Actively Recruiting

Loading map...

Research Team

K

Kristina Pfau, MD, FEBO

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

The ADAPT Study: An Open-label, Long-term Safety Study of IN...

Gene Mutations

Actively Recruiting

5 locations

CHOPXE - Analysis of Choriocapillaris Flow Deficits in Patie...

Pseudoxanthoma Elasticum

Actively Recruiting

1 location

Impact of Optimized Recruitment and Follow-up of Patients Wi...

Pseudoxanthoma Elasticum

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here